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ABSTRACT 
Purpose: To evaluate donor site clinical morbidity and changes in kinematic gait 
parameters after the harvest of a vascularized free fibula flap (VFFF) for facial 
reconstruction. 
Methods: Fourteen patients (50 ± 15 years) were enrolled in a longitudinal study. Every 
patient underwent a double evaluation performing a pre-surgical and a 6-months post-
surgical assessment. Subjective donor-site evaluation was carried out through non-
structured clinical questioning about pain, paresthesia, walking ability, restrictions in 
activity. Further subjective evaluations were assessed through the Western Ontario and 
McMaster Osteoarthritis Index (WOMAC(®)) and the Point Evaluation System for Lower 
Extremity Fibulectomy (PESLEF).  A clinical evaluation on the donor site assessed 
muscular deficits, sensibility disturbance and wound healing. Temporal and spatial 
kinematic parameters were measured through gait analysis during overground walking at 
a comfortable speed.  
Results: Post-surgical clinical examinations detected one patient affected by neurological 
disorder and three patients with donor-site pain. Ten patients (71%) declared no residual 
alterations in the operated leg. On average, the WOMAC score was 367/2400 and the 
PESLEF score was 19/24. Pre-post surgical gait analysis comparison showed no significant 
differences in gait parameters except for a 6% reduction of the double support phase. 
Stance values were higher in the operated limb in both evaluations (+1.3% presurgey; 
+1.8% postsurgery). No alterations were detected in the range of motion of lower limbs 
joints.  
Conclusion: Considering the slight modification of the gait pattern, that is not usually 
perceived by patients, VFFF harvest was generally associated to successful functional and 
subjective outcomes of the donor site. 
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INTRODUCTION 
The vascularized free fibula flap (VFFF), first introduced by Taylor et al.1 in 1975 and 
subsequently adapted to jaw reconstruction by Hidalgo2, is the most reliable and effective 
way to reconstruct facial composite bone and soft tissue defects3-6. In the last 40 years 
several other techniques including plates, local flap and other free flaps have been 
proposed without achieving the same morphological, aesthetic and functional outcome7-9. 
The characteristic of the VFFF donor site allowed the development of multiple variables of 
the flap; it can be harvested in its osteomuscular classic variant or in its only bone 
composition. Besides, a skin paddle can be associates to provide skin covering of the 
defect10. The VFFF can be manipulated through multiple osteotomies to adapt its shape to 
the bone defect, and its bone thickness consents the positioning of osteointegrated 
implants for the subsequent dental rehabilitation3,11. 
The surgical procedure causes the loss of the normal leg anatomy. Several lower limb 
muscular insertions take place on the fibula and necessarily partial muscular detachment 
must be performed10. Muscular deficits have been described, especially related to flexor 
and extensor hallucis longus muscles. Tissue stretching can lead to local hypoesthesia and 
disaesthesia due to minor nerve impairment, whereas major abnormalities can be 
prevented by sparing the common peroneal nerve by preserving the first six centimeters 
of the fibula bone12. Thus, weakness, ankle instability, toe-deformity and difficulties in 
walking have been described as mixed muscular-nervous consequences of the flap 
removal6,12-15. 
Although the efficacy of the reconstruction has already been demonstrated in multiple 
publications4,5,13, few investigations described the donor site outcome after the harvest, 
generally using a qualitative approach based on clinical assessments3,6,13,16-18 . A 
quantitative evaluation after VFFF harvest through computerized gait analysis has been 
performed by few laboratories, often with non-concordant results due to different study 
protocols, as summarized in Table 13,10,12,14,19-22. Most studies collected data only after 
surgery, with or without the concomitant assessment of a control group. Maurer-Ertl et 
al.12 compared the donor limb to the healthy one, while only Lee et al.22 and Macdonald et 
al.23 performed a quantitative longitudinal study comparing pre and post surgical gait 
analyses. 
The aim of the current longitudinal study was to quantitatively assess the donor site 
morbidity after VFFF removal for maxillofacial reconstruction. The patients were evaluated 
before and six months after the VFFF harvest to enable a correct donor site healing process 
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and detect any residual functional alteration. Questionnaires, clinical examinations and 
computerized gait analysis were performed; gait kinematics temporal and spatial 
parameters were investigated to outline walking pattern differences. 
 
 
MATERIALS AND METHODS 
Study population 
At the Maxillo-Facial Surgery unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore 
Policlinico of Milan, maxillary composite defects including bone tissue are usually 
reconstructed with VFFF harvest. In the mainframe of an Italian multicentric collaborative 
study, 14 patients who underwent VFFF removal and subsequent facial reconstruction 
consented to participate in the pre and post- surgical analysis. Sample size was estimated 
according to previous literature data about gait variables measured in patients submitted 
to VFFF removal vs. healthy controls14. To obtain an 80% power with an alpha level of 
0.05, 10 patients were considered sufficient. 
The patients (7 females, 7 males) were aged 23 to 70 years; 13 patients had a 
mandibular reconstruction, and one a maxillary one; seven of the flaps were osteo-
myocutaneous, six contained only bone, and one was osteocutaneous (Table 2). 
Patients with general conditions not-complying with long surgery-procedures were 
excluded. Besides, patients with previous or current traumas or important vascular, 
nervous and skeletal pathologies or abnormalities in their lower limbs were not suitable 
candidates to VFFF and were not included in the evaluation. 
Every patient was evaluated before surgery and 6 months after it. The study followed the 
principles stated in the Declaration of Helsinki , and it was approved by the local Research 
Ethics Committee. All patients provided voluntary written informed consent to participate 
to this study. 
 
Clinical Analysis 
Subjective donor-site evaluation was assessed through two validated questionnaires: the 
Western Ontario and McMaster Osteoarthritis Index (WOMAC(®)) and the Point 
Evaluation System for Lower Extremity Fibulectomy (PESLEF, Table 3). The WOMAC 
consists of 24 items divided into 3 subscales: pain in various situations and physical 
activities, lower limb stiffness and physical impairment in daily life24. Each question is 
given a 0-100 score, where higher scores denote higher impairment; the total score is up to 
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2400. 
The PESLEF score, modified by the PES score used by Bodde et al.20, evaluates six different 
areas: pain, paresthesia, gain recovery, activities restrictions, gait impairment and surgical 
wound20. The patient should indicate the functional impairment with a 0-4 value; the 
higher the impairment, the higher the score, ranging from a total value of 0 (no problems) 
to 24 (the worst condition).   
Additionally, the patients were asked to answer to a set of non-structured clinical questions 
before performing the gait analysis. The questions surveyed different areas through 
restriction in activities and hobbies in everyday life, motor and sensibility functions, pain 
and complaining about the intervention. A physical evaluation was performed to detect 
sensibility disturbance, wound alteration, claw-toe deformity and to assess flexor-
extensor toe and fingers activity. 
Gait Analysis 
Data collection was performed at Movement Analysis Laboratory (LAM), Department of 
Biomedical Sciences, Università degli Studi of Milan. For spatiotemporal gait parameters 
gathering, a 9-camera optoelectronic movement analysis system (SMART-E, BTS spa, 
Milano, Italy) was used19. A set of 29 passive infrared retro-reflexive markers were fixed 
with adhesive tape on the following anatomical landmarks: glabella, tragus, acromion, C7 
spinous process, radial epicondyle, ulnar styloid process, anterior superior iliac spine, S1 
spinous process, greater trochanter, medial and lateral femoral epicondyle, tibial 
tuberosity, medial and lateral malleolus, calcaneus, tip of the foot. 
Each subject wore comfortable trainers and thin and adherent clothes to improve marker 
proximity to the bone landmarks. All kinematic data were collected with a sample 
frequency of 60 Hz. 
The 3-Dimensional reference system was defined as follows: 1) x-axis; parallel to the 
longitudinal direction of the walking aisle, directed forward; 2) y-axis; orthogonal to the 
ground, directed upward; 3) z-axis; orthogonal to the sagittal plane, directed right. For each 
data collection the system was calibrated, with correction of optical and electronic 
distortions. A preliminary recording of a 5-s static image of the patient standing in 
orthostatic position with arms slightly abducted and looking forward was made. The 
patients were then asked to walk overground at their self-selected comfortable walking 
speed over an 8 m aisle; ten gait trails were consecutively recorded. For each trial, only the 
central 5 m of the path were analyzed by the optoelectronic system, excluding the initial 
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and final 1.5 m to eliminate transient acceleration and deceleration phases25. Before data 
collection each patient performed two gait trials to become familiar with the laboratory 
environment. 
Each film acquisition was followed by the gait cycle definition setting two subsequent 
ipsilateral heel strikes as extremes. Double support, swing and stance phase were 
calculated as a percentage of cycle time. Cadency, velocity and stride length were 
assessed26. Step width was evaluated as the mean sagittal distance between the medial 
malleoli identified in each acquisition instant. The Range of Motion (RoM) of hip, knee, 
and ankle flexion-extension was also calculated. Each bilateral parameter (stance, swing, 
duration of the cycle and flexion-extension RoMs) was analyzed separately in the healthy 
and operated limb. All calculations were performed using SMART-E Analyzer software. 
 
Statistical Analysis 
Mean and standard deviation of pre and post surgical variables were calculated. Given the 
sample size and the normal data distribution, Student's t test for paired samples was used to 
compare pre and post surgical unilateral data. For bilateral variables, the 2 way factorial 
Analysis Of Variance (ANOVA) was used to compare the pre and post surgical assessment 
(Factor 1) and healthy and operated limb (Factor 2); the time x side interaction was also 
computed. All tests were carried out with p values <0.05 considered statistically significant. 
All data are presented as mean and standard deviation. 
 
RESULTS 
Clinical analysis 
The average WOMAC score was 367 and the PESLEF questionnaire was 19. The non-
structured clinical questions found that ten patients (71%) declared no residual 
alterations in the operated leg (Table 2). Three patients (21%) declared occasional pain 
related to the operated limb. The pain was referred during activities for patient F2, during 
prono-supination movements for M4, and to be always present for M5 (WOMAC score 
350/500). Patient M6 reported stiffness in the morning after awakening or after inactivity, 
with a WOMAC score of 160/200. Patient F6 claimed claw toe deformity, albeit no further 
complaints were reported. 
The clinical examinations found muscular impairment in three patients (21%). Patient M5 
had an extensor hallucis and digitorum longus muscles deficit (14%). Patient F6 was 
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affected by extensor digitorum longus deficit and M6 by flexor hallucis longus deficit. 
Significant paraesthesia was detected on patient M5 (7%). The aesthetic aspect of the 
wound was generally satisfactory; only one wound dehiscence was reported. 
Gait analysis 
Quantitative analysis between pre and post-surgical acquisitions showed few alterations 
in temporal and spatial parameters indicating a mildly affected gait pattern, and only 
patients with muscular impairment (F6, M5, and M6) had changes in the support phases. 
For bilateral variables (Table 4), the analysis of variance found no significant effects of 
time (pre and post surgical assessment; all p values > 0.05), but showed a statistically 
significant difference between the healthy and operated limb for stance and swing phases: 
stance values were higher in the operated limb in both evaluations (p = 0 .002). 
Comparison of lower limbs flexion-extension RoMs showed no significant alterations for 
hip, knee and ankle joints. In no occasion the time x side interaction was significant (p > 
0.05). 
The quantitative analysis of unilateral variables detected a significant decrease in the 
double support phase (pre 28.1%; post 26.3%; t test, p = 0.05). All the other comparisons 
were not significant (Table 5). Figure 1 shows the percentage changes before and after 
surgery in the healthy and operated limbs: for bilateral variables, all changes were lower 
than 5%, while larger variations were observed for unilateral ones (double support, 6%; 
step width, 21%). 
 
DISCUSSION 
Walking is a precious and fundamental activity. Being able to move independently is 
fundamental to achieve independence and to improve and safeguard health status. The 
aim of the present study was to perform a longitudinal quantitative analysis of mid-term 
residual gait impairment after VFFF harvest, coupling subjective, clinical and instrumental 
assessments. 
The subjective perception of leg impairment after VFFF was generally low. Ten patients 
(71%) reported no residual alteration at the donor leg six months after the operation. The 
questionnaire's assessment showed significant complaints in three patients (M5, M7, F3). 
M5 presented muscular impairment, paresthesia alongside instability while walking; the 
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gait analysis of this patient provided alteration supporting his scores at questionnaires 
and answers at clinical questions. In particular he showed a 4-5% reduction of stance 
duration and a 7.7% increase in the double support phase.  
M7 showed no significant alterations in the gait temporal parameters, but at the time of 
the evaluation he had recently finished the radiotherapy treatment. After surgery, his hip 
flexion RoM increased on the healthy side (+10.6%) and decreased on the operated one (-
4.4%). F3 reported no deficit at the non-structured clinical questioning, but she indicated 
problems in all three domains of WOMAC. Her gait analysis showed a 10% increase in the 
double support phase. 
At clinical examination one patient (7%) showed claw toe deformity, a sing reported in 
several studies with a rate of 0-27%, well in accord with the current findings3,6,12,14-18,20. 
Pain was referred by three patients (21%), mainly described as a discomfort feeling while 
performing activities, whereas only one patient reported pain at rest. Pain can be 
explained by adhesion of the dissected tissues during the healing process and by nerve 
impairment during the operation. Overall, pain results were satisfactory and 93% of the 
patients were not taking pain medications. On quantitative gait analysis alterations were 
detected only in the patients who reported muscular impairment (F3, M2, M5, and M6) 
with changes in support phases.  
Alongside with clinical evaluations, some studies performed instrumental gait analyses 
comparing the results with a control group3,10,14,19,20,21. These studies did not discriminate 
potential differences due to patient's habits and systemic illnesses. Most of the patients 
perform this surgical procedure due to cancer local invasion of the maxillary bones. 
Tumors in this area are often related with a history of smoke and alcohol which could 
affect the individual gait ability distorting the comparison with a healthy group10. A 
different approach was used by Maurer-Ertl et al.12 who compared the operated and 
healthy limb within each patient. Unfortunately, this assessment can offer information 
only about bilateral gait variables. The current investigation was designed as longitudinal 
to eliminate every cross- sectional study bias. 
Furthermore, most of the studies which performed a gait analysis after VFFF removal 
made their post-operative evaluation without following a strict temporal criterion but 
defining a post-surgical moment when all the patients were analyzed3,10,12,14,19-21,27. Despite 
the advantages in the data collection managing, data are influenced by an evaluation 
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performed with different healing stages. Indeed, before performing the post-surgical 
assessment, an appropriate amount of time should be expected to enable the evaluation at 
a quite stable limb situation. Therefore, we defined the postoperative assessment 
following two criteria: 1) a fixed postoperative evaluation; 2) a time interval consenting an 
appropriate leg recovery before performing the assessment. According to Lee et al.22, a 3-
months interval could be sufficient to allow a full recovery from the VFFF harvest, even if 
Feuvrier et al.14 found significant improvements in temporal gait parameters with a longer 
follow-up (up to 104 months). 
These two criteria led us to choose a 6-months postoperative evaluation in order to assess 
all the patients at the same stage of the healing process, at a stable leg condition, with a 
definitive gait pattern, avoiding temporarily discomfort which could affect the data 
collecting and patients will to join the study. Indeed, patients submitted to radio or 
chemotherapy could still not have completely recovered even though after six months 
these alterations should be minimal; in our patient group only two patients underwent 
radiotherapy (Table 2). 
Other two studies performed longitudinal post-surgical evaluations of gait with a fixed 
follow- up time22,23. Macdonald et al.23 collected longitudinal data 3 months after surgery 
in eight patients, and concluded that the surgical procedure was associated with little 
objective gait impairment. Lee et al.22 acquired 20 patients 1 month postsurgery and 12 of 
them again 3 months after surgery; 8 patients refused to be analyzed because they felt 
little discomfort during walking. The authors found a reduction of cadency, speed and 
stride length after one month albeit in the following evaluation the walking pattern was 
normal
22
. Indeed, they may have underestimated possible gait alterations by not 
evaluating the entire group in the second assessment. According to literature and our 
findings, the correct restoration of the gait pattern is achieved by training; patients who 
perform physical rehabilitation obtain faster and better results14,15,21,28,29. 
A gait cycle is composed of an alternation of swing and stance phases. The stance phase, 
defined as the soil contact phase, is divided in heel strike, foot flat, midstance, heel off and 
toe off. The double support is the phase in which both feet take contact with the floor; it is 
included between the heel strike and the contralateral toe off. The stance phase is 
composed by an initial double support phase, a mid-term single support phase and a 
finally double support phase.26 In the present study, the double support phase significantly 
decreased after surgery. This decrease could be explained by a combination of residual 
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muscular impairment and increase of velocity. Accordingly, other investigations detected 
a double support reduction explained by an insufficient function of the flexor hallucis 
longus muscle which resulted in anticipated cessation of the preswing phase15,21,22. In our 
patient group only one patient suffered this alteration (7%) and the analysis of his double 
support showed a reduction of 11.64% of the pre-operative value against an average 
decrease of 6.4%. 
Furthermore, albeit the velocity was not significantly increased (pre surgery, 1.13 m/s; 
postsurgery, 1.19 m/s; t test, p = 0.174), its change could have influenced the double 
support measurement. The increase of velocity causes an increase of the swing and a 
reduction of the double support and stance phases as widely described in literature26. In 
contrast with our findings, Siegel et al.30 described an increased double support phase in 
their patient group caused by post-operative leg pain. The discordance could be 
explained by the little residual leg pain of the present patients as demonstrates by the low 
percentage taking pain medications (7%). 
The comparative analysis between bilateral parameters showed a significant difference in 
the stance phase between the healthy and operated leg. This divergence was due to a 
longer stance phase of the operated leg detected in both pre and post-surgical assessments, 
respectively, of 0.9 and 1.2% (Table 4). The surgical intervention led to a non-significant 
decrease in both limbs maintaining the asymmetry. Literature does not report clear 
references to stance asymmetry in healthy subject during gait even if asymmetry in weight 
loading during standing has been documented31. This little variation can be considered 
physiological, but further assessments in larger groups are necessary. Indeed, no significant 
asymmetries between the healthy and operated legs were reported in other 
investigations14. Rendenbach et al.32 longitudinally analyzed the single leg postural sway 
in 27 patients before and 8 months after VFFF fibula free flap. Preoperatively, the donor 
leg values were all somehow larger (range 1.1-1.3%) than those collected in the 
contralateral limb, thus showing some asymmetry in balance32. After surgery, all values 
recorded on the donor leg significantly increased, while no variation were observed 
contralaterally. 
In the present study, patients were asked to walk at their preferred velocity while 
performing the test. No velocity, cadency or stride length alteration were detected, in 
accord with previous investigations12,21,23. In contrast, other studies found a reduction of 
velocity14,20, even if Feuvrier et al.14 claimed that velocity improves with time after surgery. 
Hadouiri et al.10 measured a significant reduction in velocity but they used a different 
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walking test designed for fatiguing the subjects. Bodde et al.20 found an increased 
variability in stride time when the patients were asked to walk faster or when they were 
submitted to a double task condition. A similar finding was reported by Feuvrier et al.14 
and ascribed to a more cautious walking pattern, as also reported by Baj et al.19 for stairs 
descent.  Rendenbach et al.32 observed a significant reduction in lower limb maximum peak 
power, but did not test gait kinetics The mild velocity increase detected in our analysis, due 
to the longitudinal structure of the study, may be explained by a major knowledge of the 
gait trail in the postoperative assessment jointly to the lack of major gait alterations. 
In conclusion, six months after the operation the analyzed patients who underwent VFFF 
removal suffered little or no alterations of their gait pattern with a mild double support 
decrease as the only significant alteration. An electromyographic study of the posterior leg 
muscles could better clarify the flexor hallucis longus muscle impairment. An additional 
longitudinal study with a larger number of patients could be designed with a two years 
postsurgical evaluation to verify the total restoration of the gait pattern through the 
regaining of the pre-operative double support. Furthermore, during the restoration of the 
normal gait characteristics, there may be different gait pattern categories, beyond 
differences due to radio-chemotherapy and different surgical techniques33, which might 
explain the divergences between studies with similar protocol. 
The clinical examination observed that patients were usually unaware of the mild gait 
alteration and they were generally satisfied about their condition. On these bases we can 
conclude that VFFF is a safe, effective surgical procedure which leads to minor and not- 
perceived donor site impairment. 
Future investigations should increase the number of patients, assess a longer follow-up 
and investigate other daily life locomotor activities like stairs climbing19 and prolonged 
gait10. 
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Table 1. Donor site morbidity: gait analysis studies after VFFF. 
 
 
Study Patients Age (mean, 
range; years) 
Follow up time 
(mean, range; 
months) 
Study design1 Analyzed 
condition2 
Main results3 
Baj19 8 (4 M, 4 F) 55 (17-76) 28 (6-60) C - CG Stairs ascent/ No major alterations found; in descent ↑ RoM of 
     descent pelvis inclination 
Bodde20 10 (6 M, 4 F) 58 (19-80) 33 (6-87) C - CG Treadmill ↓V; ↑ variability under additional cognitive and 
      visual loads or increased velocity 
Chou21 11 52 (38-76) 27 (10-68) C - CG SW ↓ DS 
Feuvrier14 11(7 M, 4 F) 53 (17)4 28 (5-104) C - CG Treadmill ↓ V; C; SL; ↑ variability in spatio-temporal 
      variables 
Hadouiri10 11 (4 M, 7 F) 59 (47-63)5 15 (11-31)5 C - CG 6MWT ↓ V;C; SL; DS; walked distance 
Lee22 20 (13 M, 7 46 (19–68) 1; 3 L SW ͳ month: ↓ V; C; SL; peak plantarflexion; RoM 
 F)     ͵ months: ↓ peak plantarflexion in swing 
Lin3 7 (5 M, 2 F) 53 (45-68) 34 (15-61) C - CG SW No major alterations found (bilateral VFFF) 
Maurer-Ertl12 9 (8 M, 1 F) 33 (18-59) 33 (7-59) Healthy vs SW No alterations found 
    operated leg   
 
1Study design: L = Longitudinal; C = Cross sectional; CG = Control Group 
2Analyzed conditions: 6MWT= Six-Minute Walk Test; SW = Straight Walkway 
3RoM = Range of Motion; V = Velocity; DS = Double Support; C = Cadency; SL = Stride Length 
4Standard deviation 
5Median, Interquartile range 
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Table 2. Study population. 
 
 
Patients Age 
(years) 
Height 
(cm) 
Weight 
(kg) 
BMI 
(kg/m2) 
Pathology Free flap 
variant1 
Notes 
F1 54 169 51 17.9 Left parasymphysis OC - L - 
     jaw pseudarthrosis   
F2 38 176 101 32.6 Right parasymphysis B - R Pain 
     jaw keratocyst   
F3 70 160 58 22.7 Left mandibular OMC - R - 
     ramus SCC2   
F4 45 170 75 26.0 Left mandibular B - L - 
     ramus keratocyst   
F5 53 157 45 18.3 Right mandibular B - L - 
     ramus adenoid cystic   
     carcinoma   
F6 59 163 56 21.1 Superior maxillary OMC Extensor hallucis 
     atrophy mini - L longus deficit 
F7 61 147 51 23.6 Right mandibular OMC - 
     body mini - L  
     mucoepidermoid   
     carcinoma   
M1 64 178 105 33.1 Left mandibular OMC - R Radiotherapy 
     ramus SCC   
M2 23 171 64 21.9 Right mandibular B - L - 
     body keratocyst   
M3 27 173 67 22.4 Left retromolar OMC - R - 
     trigone SCC   
M4 30 158 84 33.6 Right mandibular B - L Pain 
     ramus   
     ameloblastoma   
     recidive   
M5 61 172 56 18.9 Left mandibular body OMC - R Extensor digitorum and 
     and mouth floor SCC  hallucis longus deficit – 
       Pain – Paraesthesia 
       Wound dehiscence 
M6 59 168 94 33.3 Left retromolar B - mini - Flexor hallucis longus 
     trigone L deficit - Stiffness 
     mucoepidermoid   
     carcinoma   
M7 59 178 80 25.2 Jaw symphysis and OMC - R Radiotherapy 
     mouth floor SCC   
 
Mean 50.21 167.14 70.50 25.04 
SD 15.02 9.03 19.63 5.81 
 
1B = bone; OC = osteocutaneous; OMC = osteo-myocutaneous; L = left; R = right; 
mini = minimally-invasive technique (Baj et al.33) 
2SCC = squamous cell carcinoma 
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Table 3. Subjective evaluations assessed through the Western Ontario and McMaster 
Osteoarthritis Index (WOMAC(®)) and the Point Evaluation System for Lower Extremity 
Fibulectomy (PESLEF). 
 
Patients 
WOMAC PESLEF 
Pain  
(max 500) 
Stiffness 
(max 200) 
Physical impairment 
(max 1700) 
Total(max 
2400) 
Categories' 
score1 
Total 
(max 24) 
F1 120 40 190 350 2/2/4/4/2/4 18 
F2 75 0 45 120 1/4/1/4/4/4 18 
F3 210 120 430 760 1/2/2/4/2/4 15 
F4 0 0 0 0 4/3/4/4/4/4 23 
F5 15 10 15 40 4/4/4/4/4/4 24 
F6 0 30 180 210 4/2/2/4/2/4 18 
F7 20 0 0 20 3/4/4/4/4/4 23 
M1 95 0 55 150 4/3/2/4/2/3 18 
M2 20 0 100 120 3/3/3/4/4/3 20 
M3 0 0 35 35 4/4/2/4/2/4 20 
M4 130 70 50 250 3/4/2/4/4/4 21 
M5 330 145 930 1405 2/2/2/2/2/2 12 
M6 0 160 160 320 4/2/3/4/2/4 19 
M7 325 135 895 1355 1/3/3/2/2/4 15 
1Pain; Paresthesia; Gait recovery; Activities restrictions; Gait impairment; Surgical wound 
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Table 4 .Pre- and post surgery gait analysis. Bilateral variables. 
 
 Healthy limb Operated limb ANOVA 
 Pre Post  Pre Post  H/O
2
 Pre/Post
3
 
Variable  Mean SD Mean SD Δ1 Mean SD Mean SD Δ1 p P 
Stance (%) 63.6 1.7 62.5 1.9 -1.1 64.5 1.7 63.7 1.9 -0.8 0.002 0.057 
Swing (%) 36.4 1.7 37.5 1.9 1.1 35.5 1.7 36.4 1.9 0.9 0.002 0.057 
Duration (s) 1.13 0.07 1.11 0.09 -0.02 1.13 0.07 1.11 0.09 -0.02 1.000 0.084 
RoM hip F (deg) 41.19 5.04 41.35 4.80 0.16 42.90 2.73 41.85 3.73 -1.05 0.361 0.346 
RoM knee F (deg) 68.37 3.45 67.27 5.11 -1.1 70.09 3.49 68.14 6.11 -1.95 0.239 0.471 
RoM ankle F (deg) 29.34 4.36 29.19 5.28 -0.15 29.58 4.21 28.36 2.80 -1.22 0.802 0.394 
1 Delta refers to post-pre difference 
2 P values refer to Healthy-Operated comparison (2-way ANOVA). Values in bold are significant (p < 0.05) 
3 P values refer to Pre-Post surgery comparison (2-way ANOVA). Values in bold are significant (p < 0.05) 
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Table 5.Pre- and post surgery gait analysis. Unilateral variables. 
 
 Pre Post  Student’s t 
Variable Mean SD Mean SD Δ1 P value2 
Velocity (m/s) 1.13 0.11 1.19 0.22 0.06 0.174 
Cadency (step/s) 0.89 0.05 0.91 0.08 0.02 0.100 
Double Support (%) 28.1 3.4 26.3 3.4 -1.8 0.050 
Step width (cm) 7.4 2.9 7.9 3.3 0.5 0.612 
Stride length (m) 1.28 0.11 1.29 0.14 0.01 0.742 
1 Delta refers to post-pre difference 
2 P values refer to pre-post comparison (Student’s t test for paired samples). Values in 
bold are significant (p < 0.05) 
 
Figure legend 
Figure 1: Percentage changes before and after surgery in the bilateral and unilateral gait 
variables (mean ± 1 SD). 
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